SAGE - Sage Therapeutic - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SAGE is currently covered by 20 analysts with an average price target of $22.91. This is a potential upside of $17.43 (318.07%) from yesterday's end of day stock price of $5.48.

Sage Therapeutic's activity chart (see below) currently has 367 price targets and 344 ratings on display. The stock rating distribution of SAGE is 73.2% HOLD, 24.74% BUY and 2.06% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 49.3% with an average time for these price targets to be met of 152.13 days.

Highest price target for SAGE is $26, Lowest price target is $4, average price target is $22.91.

Most recent stock forecast was given by PAUL MATTEIS from STIFEL on 16-Dec-2024. First documented stock forecast 12-Aug-2014.

Currently out of the existing stock ratings of SAGE, 71 are a HOLD (73.2%), 24 are a BUY (24.74%), 2 are a SELL (2.06%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$6

$0.39 (6.95%)

$20

8 days ago
(16-Dec-2024)

13/24 (54.17%)

$0.49 (8.89%)

332

Sell

$4

$-1.61 (-28.70%)

$4

1 months 3 days ago
(21-Nov-2024)

17/34 (50%)

$-1 (-20.00%)

142

Hold

$9

$3.39 (60.43%)

$10

1 months 3 days ago
(21-Nov-2024)

7/14 (50%)

$4 (80.00%)

241

Hold

$14

$8.39 (149.55%)

$14

1 months 4 days ago
(20-Nov-2024)

8/21 (38.1%)

$9.09 (185.13%)

193

Hold

1 months 4 days ago
(20-Nov-2024)

0/6 (0%)

$24.48 (53.78%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SAGE (Sage Therapeutic) average time for price targets to be met?

On average it took 152.13 days on average for the stock forecasts to be realized with a an average price target met ratio 49.3

Which analyst has the current highest performing score on SAGE (Sage Therapeutic) with a proven track record?

JOHN NEWMAN

Which analyst has the most public recommendations on SAGE (Sage Therapeutic)?

John Newman works at CANACCORD and has 5 price targets and 4 ratings on SAGE

Which analyst is the currently most bullish on SAGE (Sage Therapeutic)?

Gbola Amusa with highest potential upside - $214.14

Which analyst is the currently most reserved on SAGE (Sage Therapeutic)?

James Lee with lowest potential downside - -$1.86

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?